In this study, we aimed to evaluate the effects of a drug with p32/C1QBP as a specific target to understand the molecular and cellular mechanisms underlying the oncogenic functions of C1QBP in colon cancer cells. This evidence concerns the gene C1QBP and malignant colon neoplasm.